US stocks ended little changed on Wednesday as worries about bank regulation and a setback for drug company Pfizer offset signs of improvement in the labour market and services sector. Pfizer Inc, the world's largest drugmaker, fell 1.6 percent after its Alzheimer's drug did not meet the main goals of a late-stage clinical trial, weighing on the Dow industrials.
0 comments
Post a Comment